Endometriosis: benign, malignant, or something in between?
Other
OA: gold
CC0
⤵ 20 in-corpus citations
AI-generated summary
This paper explores the controversial classification of endometriosis, considering its benign, malignant, and intermediate characteristics within the spectrum of gynecological conditions.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (7)
- Activation of mutated K-ras in donor endometrial epithelium and stroma promotes lesion growth in an intact immunocompetent murine model of endometriosis via openalex
- Cancer-Associated Mutations in Endometriosis without Cancer via openalex
- Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer via openalex
- W1970527559 via openalex
- W2130344626 via openalex
- W2305551225 via openalex
- W2048069897 via openalex
Cited by (23)
- Somatic Cancer Driver Mutation Analysis in Endometriosis with Tumor-like Presentations: A Case Series Study 2026
- Enacting gendered pathologies: Diffraction in medical practices of treating endometriosis and infertility 2026
- Endometriosis: A Cancer-Like Phenomenon 2026
- Living with acuteness in chronic illness: The temporal underpinnings of endometriosis 2025
- The effectiveness of surgical and conservative treatment of patients with endometriosis of the uterine scar after cesarean section 2024
- The Comparative Invasiveness of Endometriotic Cell Lines to Breast and Endometrial Cancer Cell Lines 2023
- Endometriosis: Cell Death and Cell Signaling Machinery 2023
- Clinical and anamnestic features of patients with endometriosis of an incompetent uterine scar after cesarian section 2022
- Combination of Ferulic Acid, Ligustrazine and Tetrahydropalmatine attenuates Epithelial-mesenchymal Transformation via Wnt/β-catenin Pathway in Endometriosis 2021
- Combination of ferulic acid, ligustrazine and tetrahydropalmatine inhibits invasion and metastasis through MMP/TIMP signaling in endometriosis 2021
- How Does Endometriosis Lead to Ovarian Cancer? The Molecular Mechanism of Endometriosis-Associated Ovarian Cancer Development 2021
- An Integrated Genomic Approach Identifies HOXC8 as an Upstream Regulator in Ovarian Endometrioma 2020
- The ultrasound of subcutaneous extrapelvic endometriosis 2020
- Evaluation of PTEN and Ki67 Expression in Typical and Atypical Endometriosis and Endometriosis Associated Ovarian Cancer 2020
- Endometriosis-associated ovarian carcinomas: insights into pathogenesis, diagnostics, and therapeutic targets-a narrative review 2020
- Inhibition of Jiawei Foshou San on invasion and metastasis through MMP/TIMP signaling in endometriosis 2020
- Association between endometriosis and gynecological cancers: a critical review of the literature 2020
- A mouse model of endometriosis mimicking the natural spread of invasive endometrium 2019
- The Origin and Pathogenesis of Endometriosis 2019
- Novel CTCF mutations in Chinese patients with ovarian endometriosis 2018
- Perimenopausal management of ovarian endometriosis and associated cancer risk: When is medical or surgical treatment indicated? 2018
- The Endometriotic Tumor Microenvironment in Ovarian Cancer 2018
- Anti-endometriosis Mechanism of Jiawei Foshou San Based on Network Pharmacology 2018
Source provenance
- europepmc
- last seen: 2026-10-22T06:08:12.857683+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:20:50.926721+00:00
License: CC0
· commercial use OK